Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT vs Vancomycin in Initial CDI
NCT03107169Completed
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Feb 2015
- Primary completion
- Sep 2015
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, open-label trial of Fecal Microbiota Transplantation Capsule in Clostridium difficile infection (CDI) (2 arms), sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Decrease in number of evacuations at 2 days. Started Feb 2015; status: completed.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03107169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107169.